Showing results (11-20 of 59) with videos related to
Sort By:
Pageof 6
Immunotargets and Therapy|December 11, 2023
<i>NOTCH1</i> Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung CancerQingyuan Huang, Hang Cao, Qianlan Yao, et al.Genomics, Proteomics & Bioinformatics|January 15, 2021
Kinase-substrate Edge Biomarkers Provide a More Accurate Prognostic Prediction in ER-negative Breast CancerYidi Sun, Chen Li, Shichao Pang, et al.Virchows Archiv : an International Journal of Pathology|August 5, 2021
Epithelioid leiomyosarcoma of broad ligament harboring PGR-NR4A3 and UBR5-PGR gene fusions: a unique case reportHuayan Ren, Yimin Li, Qianlan Yao, et al.The Oncologist|September 14, 2020
Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal CancerYaqi Li, Qianlan Yao, Long Zhang, et al.Frontiers in Oncology|June 14, 2021
A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian CancerHui Li, Shuoer Wang, Qianlan Yao, et al.Scientific Reports|June 16, 2017
Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to ageLeilei Wu, Shichao Pang, Qianlan Yao, et al.Histopathology|July 19, 2022
Uterine tumours with myogenic differentiation harbouring SRF::RELA fusionsYimin Li, Dan Huang, Rui Bi, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 11, 2018
Systematic identification of rabbit LncRNAs reveals functional roles in atherosclerosisJia Li, Qianlan Yao, Fangyoumin Feng, et al.Annals of Translational Medicine|April 14, 2021
Germline and tumor <i>BRCA1/2</i> mutations in Chinese high grade serous ovarian cancer patientsGang Ji, Qianlan Yao, Longlong Bao, et al.Journal of Cancer Research and Clinical Oncology|July 13, 2021
Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomasGang Ji, Longlong Bao, Qianlan Yao, et al.Pageof 6